Results 161 to 170 of about 14,304 (250)

Biomarkers in Schizophrenia: Current Approaches and New Developments—A Literature Review

Behavioural Neurology
Schizophrenia (SZ) is categorized as a chronic severe highly heritable brain disease. Symptoms include positive, negative, and cognitive symptoms. Despite numerous theories concerning the etiopathogenesis of SZ, the symptoms, although characteristic in ...
Alicja Sierakowska, Ewa Niewiadomska, Sebastian Łabuda, Anna Bieniasiewicz, Mateusz Roszak, Beata Łabuz-Roszak   +5 more
doaj   +1 more source

Molecular and functional interdependence of the urokinase-type plasminogen activator system with integrins.

, 2003
The serine protease urokinase-type plasminogen activator (uPA), its inhibitor PAI-1, and its cellular receptor uPA-R (CD87) are of crucial importance during cellular invasion and migration, required for a variety of physio- and pathophysiological ...
Reuning, U;Magdolen, V;Hapke, S;Schmitt, M
core  

Targeting EGFR and uPAR on human rhabdomyosarcoma, osteosarcoma, and ovarian adenocarcinoma with a bispecific ligand-directed toxin

Clinical Pharmacology: Advances and Applications, 2018
Felix Oh,1 Deborah Todhunter,1 Elizabeth Taras,1 Daniel A Vallera,1,2 Antonella Borgatti2,3 1Department of Therapeutic Radiology-Radiation Oncology, Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA; 2Animal Cancer Care and Research ...
Oh F, Todhunter D, Taras E, Vallera DA, Borgatti A   +4 more
doaj  

Urokinase Plasminogen Activator Surface Receptor [PDF]

, 2020
openaire   +1 more source

Progesterone regulation of plasminogen activator inhibitor 1 (PAI-1) antigen and mRNA levels in human endometrial stromal cells

, 1992
Plasminogen activator activity decreases in the endometrium in the secretory phase of the menstrual cycle. This is partly due to decreased release of urokinase plasminogen activator in response to progesterone. Plasminogen activator inhibitor type 1 (PAI-
Casslén, B, Ny, Tor,, Urano, S
core  

The relationship of soluble urokinase plasminogen activator receptor levels with preterm premature rupture of membranes and predictive value in neonatal intensive care unit admission. [PDF]

Rev Assoc Med Bras (1992)
Koc BL, Tanacan A, Haliloglu E, Yilmaz HE, Ersak DT, Aktas BA, Kara O, Sahin D.   +7 more
europepmc   +1 more source

Beyond Fibrinolysis: Urokinase Plasminogen Activator as an Early Regulator of Obesity. [PDF]

Arterioscler Thromb Vasc Biol
Torrente D, Strickland S.
europepmc   +1 more source

Cathepsin G is associated with cerebral vascular injury in myeloid leukemia: a pathologic insight into intracranial hemorrhage. [PDF]

Res Pract Thromb Haemost
Gi T, Kai K, Shide K, Nakamura E, Oguri N, Aman M, Maekawa K, Moriguchi-Goto S, Nakai M, Shimoda K, Hisada Y, Yamashita A.   +11 more
europepmc   +1 more source

Maternal soluble urokinase plasminogen activator receptor levels in intrahepatic cholestasis of pregnancy: a predictor of neonatal intensive care unit admission. [PDF]

Rev Assoc Med Bras (1992)
Aktaş BA, Agaoglu Z, Peker BN, Başaran E, Orhan N, Özdal BB, Şahin D.   +6 more
europepmc   +1 more source

Serum profiling of uPA, PAI-1, and suPAR in systemic sclerosis: a preliminary study on analytical aspects and associations with microvascular and fibrotic manifestations. [PDF]

Front Immunol
Napolitano F, Mormile I, Mignogna G, de Paulis A, Rossi FW, Montuori N.   +5 more
europepmc   +1 more source